David Horwitz
Company: USC Keck School of Medicine, Nanotherapeutics
Job title: Co-Founder
Seminars:
Properties of Therapeutic Nanonparticles 11:30 am
Provide IL-2 and TGF-β needed for targeted T cells to become Tregs that prevent immune-mediated disease Induce – TGF-β producing NK cells that support TregsInduce alloantigen specific Tregs for transplantation toleranceRead more
day: Pre-Conference Day
IL-2 Containing Nanoparticles Induce Tregs & TGF-β-producing NK Cell 4:00 pm
The tolerogenic effect of IL-2 on Tregs is TGF-β dependent TGF-β producing NK cells are essential for Treg maintenance The NPs induce TGF-β locally so that encapsulation of TGF-β is not neededRead more
day: Conference Day Two